15-min delayed · Sep 9, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 22 firms covering Insulet Corporation, 12 rate it Buy or better, 9 sit at Hold, and 1 rate it Sell or worse, a moderate buy consensus. Targets span $144.00 to $277.00, a moderate spread. The average target of $182.47 sits 32% above the current $137.92. The rating mix has stayed broadly stable, with Buy-side ratings easing from 17 to 12 over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.84 next quarter toward $7.71 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS22 ratings
Moderate Buy
Strong Buy00%
Buy1255%
Hold941%
Sell15%
Strong Sell00%
Based on 22 analysts giving stock ratings to Insulet Corporation.
As of Sep, 12 of 22 firms rate PODD a Buy (9 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
PODD EPS & revenue forecast
EPS · NEXT QUARTER
$1.84
Range $1.73 – $1.94 · 21 analysts · +19% YoY
Next period, 21 analysts expect Insulet Corporation to earn $1.84 a share (range $1.73 – $1.94), versus $1.55 a year earlier. Full-year consensus is $6.50, growing to $7.71 the year after.
REVENUE · NEXT QUARTER
$894.2M
Range $874.1M – $906.3M · 21 analysts · +14% YoY
Revenue is expected to reach $894.2M (range $874.1M – $906.3M), +14.1% year-over-year. Full-year consensus is $3.3B, rising to $3.7B next year.
Top analysts covering Insulet Corporation
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on PODD.
#1
JB
Jayson Bedford
Raymond James · Rank #196
Buy
$216.00+56.6% to target
Overall win rate
42%
+ Follow
#2
Jonathan Block
Stifel · Rank #205
Buy
$180.00+30.5% to target
Overall win rate
41%
+ Follow
#3
William Plovanic
Canaccord Genuity · Rank #243
Buy
$179.00+29.8% to target
Overall win rate
37%
+ Follow
#4
Bruce Jackson
Benchmark · Rank #374
Buy
$185.00+34.1% to target
Overall win rate
36%
+ Follow
#5
Joanne Wuensch
Citigroup
Hold
$150.00+8.8% to target
Coverage
—
+ Follow
PODD stock forecast FAQ
What is PODD's average 12-month price target?+
The 18 analysts with a live target average $182.47 for Insulet Corporation over the next 12 months, ranging from a $277.00 high to a $144.00 low.
Is PODD stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 22 analyst ratings, 12 are Buy or Strong Buy, 9 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for PODD?+
The Street-high target is $277.00 (Goldman Sachs), and the Street-low is $144.00 (TD Cowen). The average of all 18 active targets is $182.47.
How many Wall Street analysts cover PODD?+
22 analysts have an active rating on Insulet Corporation, and 18 firms carry a live 12-month price target.
Who is the most accurate analyst covering PODD?+
Among analysts who currently cover PODD, Jayson Bedford of Raymond James has the strongest overall Quantellect track record (Rank #196). Their current call is Buy with a $216.00 target.
What is Insulet Corporation's projected EPS for next quarter?+
The consensus estimate is $1.84 per share (range $1.73 – $1.94) across 21 analysts. Full-year EPS is projected at $6.50, rising to $7.71 the following year.
How much revenue is Insulet Corporation expected to report next quarter?+
Consensus revenue is $894.2M (range $874.1M – $906.3M). Full-year revenue is projected at $3.3B, growing to $3.7B next year.
Have analysts been upgrading or downgrading PODD lately?+
As of Sep, 12 of 22 firms rate PODD a Buy (9 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their PODD calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
UBS
